News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Samaritan Pharmaceuticals, Inc. (SPHC) Acquires Commercialization Rights to Market and Distribute Abiogen Pharma's Cancer Drug Abioklad in Greece, Cyprus and Turkey


3/19/2008 10:29:47 AM

LAS VEGAS, March 19, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has acquired the rights from Abiogen Pharma of Italy to distribute and sell the specialty pharmaceutical, Abioklad (Disodium Clodronate), in Greece, Cyprus, and Turkey.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES